Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2011 by Emory University.
Recruitment status was Recruiting

Study NCT01131039 Information provided by Emory University

First Received on May 21, 2010. Last Updated on February 3, 2011 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

Neoplasms
Ovarian Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Bevacizumab
Gemcitabine

More general drug interventions related to this trial

Sponsors listed in this trial

Emory University
Genentech